Background. The correlation between tumor markers (TM) and TNM stage of non‐small‐cell
lung cancer (NSCLC) has not been widely reported. Methods. TM levels (CEA, CA125 …

The diagnostic value of Cyfra 21-1 in non-small lung cancer (NSCLC) has been established,
but few studies have focused on its prognostic value. The aim of this study was to compare …

Lung cancer is sometimes difficult to differentiate from benign lung diseases expressing
nodular shadow in imaging study. We assessed the diagnostic value of two commonly used …

Simple Summary This study recruited 3272 non-small cell lung cancer (NSCLC) cases to
analyze the predictive abilities of serum tumor markers (CEA, SCC-Ag, CYFRA 21-1, NSE …

Tumor markers are beneficial for the diagnosis and therapy monitoring of lung cancer.
However, the value of tumor markers in lung cancer histological diagnosis is unknown. In …

Background: Cytokeratins are epithelial markers whose expression is not lost during
malignant transformation. Cyfra 21-1 is a cytokeratin-19 fragment that is soluble in serum …

Non-small cell lung cancer (NSCLC), which account for the most of lung carcinoma, is
sometimes difficult to differentiate from benign lung diseases presented with nodular …

The present study was designed to determine whether CYFRA 21-1, measuring cytokeratin
19, could be a specific and sensitive tumour marker for non-small cell lung cancer (NSCLC) …

The aim of this study was to evaluate the diagnostic value of three tumour markers,
squamous cell carcinoma (SCC) antigen, carcinoembryonic antigen (CEA) and CYFRA …

Purpose: The aim of this prospective study was to assess the prognostic impact of serum
tumor markers (Cyfra21-1, carcinoembryonic antigen, neuron-specific enolase, squamous …